Question 1

Has William Palmer received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $534,112 in general payments to William Palmer across 536 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean William Palmer did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about William Palmer come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
AbbVie	143	$372,585
Eli Lilly	11	$73,025
Pfizer	78	$35,326
Amgen(2 entities)	83	$25,208
Novartis	18	$18,734
Boehringer Ingelheim	11	$5,985
Bristol Myers Squibb	25	$511
UCB, Inc.	48	$387
Genentech USA, Inc.	14	$310
Mallinckrodt Hospital Products Inc.	8	$286
Pacira Therapeutics, Inc.	7	$272
Lilly USA, LLC	16	$266
GSK	18	$229
Johnson & Johnson	16	$225
Regeneron Healthcare Solutions, Inc.	10	$179
Mallinckrodt Enterprises LLC	7	$156
Janssen Scientific Affairs, LLC	1	$94
E.r. Squibb & Sons, L.L.C.	6	$81
Antares Pharma, Inc.	2	$43
Merck	3	$41
Radius Health, Inc.	3	$41
Arbor Pharmaceuticals, Inc.	2	$30
Actelion Pharmaceuticals US, Inc.	2	$29
AstraZeneca	1	$20
Boston Scientific	1	$19
United Therapeutics Corporation	1	$16
Eisai Inc.	1	$12

William Palmer

Payments from drug & device makers

Who reported the general payments

How this compares

Other rheumatology in Omaha